Search

Your search keyword '"G, Czeglarski"' showing total 5 results
Start Over Author "G, Czeglarski"
5 results on '"G, Czeglarski"'

2. [Primary radiotherapy of prostatic carcinoma--the results at Essen with 173 patients]

Author

R D, Müller, G, Czeglarski, M, Bamberg, and V, Budach

Subjects
Adult, Aged, 80 and over, Male, Carcinoma, Germany, West, Prostatic Neoplasms, Radiotherapy Dosage, Middle Aged, Combined Modality Therapy, Actuarial Analysis, Humans, Neoplasm Metastasis, Neoplasm Recurrence, Local, Aged, Neoplasm Staging, Retrospective Studies
Abstract

173 patients suffering from prostate carcinomas of stages A to C received percutaneous irradiations. The five-year survival is 100% in stage A (n = 6), 79% in stage B (n = 41), and 68% in stage C (n = 126). 116 patients received only percutaneous irradiation after needle biopsy, 30 patients were irradiated subsequently to surgical intervention, and 27 were treated by hormones during primary therapy. An analysis was made about survival, recurrence rate, metastasis-free interval, and incidence of metastases in dependence on stage, grading, and different forms of primary treatment. The importance of stage and grading as prognostic factors is confirmed by the results of this study. Extended primary therapy (surgery and/or hormones) seems to bring no benefit as compared to radiotherapy alone. Transurethral resection of the prostate as a surgical/diagnostic intervention has an unfavorable influence on the prognosis.

Published
1987

3. Radiotherapy of osteolytic lesions in multiple myeloma

Author

F. Wendt, G. Czeglarski, V. Budach, and M. Bamberg

Subjects
Cancer Research, medicine.medical_specialty, Hematology, business.industry, medicine.medical_treatment, General Medicine, medicine.disease, Osteolytic lesion, Radiation therapy, Oncology, Internal medicine, Medicine, Radiology, business, Multiple myeloma
Published
1986
Full Text
View/download PDF

4. [Primary radiotherapy of prostatic carcinoma--the results at Essen with 173 patients].

Author

Müller RD, Czeglarski G, Bamberg M, and Budach V

Subjects
Actuarial Analysis, Adult, Aged, Aged, 80 and over, Carcinoma mortality, Carcinoma pathology, Combined Modality Therapy, Germany, West, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local epidemiology, Neoplasm Staging, Prostatic Neoplasms mortality, Prostatic Neoplasms pathology, Radiotherapy Dosage, Retrospective Studies, Carcinoma radiotherapy, Prostatic Neoplasms radiotherapy
Abstract

173 patients suffering from prostate carcinomas of stages A to C received percutaneous irradiations. The five-year survival is 100% in stage A (n = 6), 79% in stage B (n = 41), and 68% in stage C (n = 126). 116 patients received only percutaneous irradiation after needle biopsy, 30 patients were irradiated subsequently to surgical intervention, and 27 were treated by hormones during primary therapy. An analysis was made about survival, recurrence rate, metastasis-free interval, and incidence of metastases in dependence on stage, grading, and different forms of primary treatment. The importance of stage and grading as prognostic factors is confirmed by the results of this study. Extended primary therapy (surgery and/or hormones) seems to bring no benefit as compared to radiotherapy alone. Transurethral resection of the prostate as a surgical/diagnostic intervention has an unfavorable influence on the prognosis.

Published
1987

5. Primary chemosensitivity and secondary drug resistance of xenografted soft part sarcomas.

Author

Budach V, Budach W, Scheulen M, and Czeglarski G

Subjects
Animals, Drug Resistance, Female, Histiocytoma, Benign Fibrous drug therapy, Humans, Leiomyosarcoma drug therapy, Mice, Mice, Nude, Neoplasm Transplantation, Neurofibroma drug therapy, Transplantation, Heterologous, Bleomycin therapeutic use, Doxorubicin therapeutic use, Ifosfamide therapeutic use, Sarcoma drug therapy, Soft Tissue Neoplasms drug therapy
Published
1989

Catalog

Books, media, physical & digital resources
See catalog results